Market News

For the fourth time since becoming Reserve Bank Governor, Michell Bullock has emphasised the central bank’s policy primacy in controlling prices by raising interest rates if inflation proves challenging to reduce. Less than a day before the release at 11:30 am on Wednesday of the Consumer Price Index for the September quarter and the CPI’s […]

Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses efficacy results for the company’s glioblastoma therapy. Peter Milios: I’m Peter Milios from the Finance News Network, and today we’re talking with Chimeric Therapeutics (ASX:CHM), market cap of around $14m. Chimeric Therapeutics is a clinical-stage therapy company focused on bringing the promise of cell

Stocks rose Tuesday as investors focused on a fresh slate of earnings reports. The Dow Jones Industrial Average gained 204 points, or 0.6 per cent. The S&P 500 added 0.7 per cent, and the Nasdaq Composite climbed 0.9 per cent. Coca-Cola reported earnings and revenue that topped estimates, sending the stock up 2.8 per cent.

It looks like another year of forbearance for shareholders in Australia’s wannabe food giant, Bega Cheese (ASX:BGA). Shareholders were informed at Tuesday’s annual meeting that they shouldn’t expect significant earnings gains in the 2023-34 financial year. In fact, the company is anticipating a “relatively flat” result compared to the 2022-23 fiscal year when ‘normalised EBITDA’

Westgold Resources (ASX:WGX) has made quite a fuss about the commencement of work at the legendary Great Fingall mine in the WA Goldfields. This statement comes just a day before the release of the company’s September quarter production and sales report on Wednesday, October 25. You might wonder why companies separate major news items when

Australian graphite stocks have experienced a significant surge after China’s recent announcement of export controls on one of the crucial battery minerals essential for electric vehicles.  China, which serves as the world’s leading graphite producer and exporter, further refines over 90 percent of the world’s graphite into materials used in various applications, including electronics and

The S&P/ASX 200 is trading 0.16 per cent higher at 6,855.1. Futures The SPI futures are up 9 points. Best and worst performers The best-performing sector is Energy, up 0.56 per cent. The worst-performing sector is Health Care, down 0.64 per cent. The best-performing large cap is Pilbara Minerals (ASX:PLS), trading 4.34 per cent higher

On Tuesday, energy and mining stocks drove gains in the Australian sharemarket. Energy stocks benefited from the rise in oil prices, with West Texas Intermediate trading around $86 per barrel. The avoidance of a Gaza invasion by Tel Aviv temporarily eased Middle East tensions. As a result, Santos saw a 0.6% increase to $7.85, and

The spotlight is on RBA Chief Michele Bullock’s speech scheduled for 7pm AEDT at the Global Markets Conference hosted by CBA in Sydney. At noon, the S&P/ASX 200 is 0.22 per cent higher at 6,859.30. The SPI futures are pointing to a rise of 30 points. Best and worst performers The best-performing sector is Energy,

Immutep (ASX:IMM) has reported promising clinical data from the INSIGHT-003 trial at the ESMO Congress 2023. In response, Immutep CSO, commented, “the compelling data that our proprietary MHC Class II agonist has generated in combination with immune checkpoint inhibitors for NSCLC patients positions efti as one of the more promising clinical candidates in immuno-oncology today.”